Watch Ticker

Cue Biopharma, Inc.

Go to Cue Biopharma, Inc. Website

$0.76

0.02 (3.36%)

Live

Previous Close

$0.7372

Day Range

$0.7372 - $0.797

Previous Day Range

$0.7064 - $0.7899

Market Cap

$55.5 million USD

Day Vol.

85323

Previous Day Vol.

211724

Currency

USD

Primary Exchange

Nasdaq

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Prnewswire - High‑Growth Oncology Market Projected For US$900bn in Revenue Despite Policy Headwinds

Despite regulatory challenges and budget cuts, the oncology market is projected to reach US$900 billion by 2034, with several biotech companies advancing innovative cancer therapies and demonstrating promising clinical trial results.

Related tickers: ONCY, CUE, VSTM, ALLO, CATX.

Read Full Article

N/A - Cue Biopharma Receives FDA Feedback on Pre-IND Briefing Document Reinforcing Company’s Intention to Advance IND Submission for CUE-401 to Address Unmet Need in the Treatment of Autoimmune Disease

Cue Biopharma received positive feedback from the FDA on its pre-IND briefing document for CUE-401, a first-in-class bispecific molecule designed to induce and expand regulatory T cells for the treatment of autoimmune diseases. The company plans to file an IND for CUE-401 after completing final enabling studies.

Related tickers: CUE.

Read Full Article

Trending Tickers

Please sign in to view